Abstract: A computer-implemented method of transcribing an audio stream can include transcribing the audio stream using a first transcribing instance having a first predetermined transcription size that is smaller than the total length of the audio stream. The first transcribing instance can provide a plurality of consecutive first transcribed text data snippets of the audio stream and the size of the first transcribed text data snippets can respectively corresponding to the first predetermined transcription size. The audio stream can also be transcribed using at least a second transcribing instance having a second predetermined transcription size that is smaller than the length of the audio stream. The second transcribing instance can provide a plurality of consecutive second transcribed text data snippets each corresponding to the second predetermined transcription size.

Abstract: A computer-implemented method of transcribing an audio stream can include transcribing the audio stream using a first transcribing instance having a first predetermined transcription size that is smaller than the total length of the audio stream. The first transcribing instance can provide a plurality of consecutive first transcribed text data snippets of the audio stream and the size of the first transcribed text data snippets can respectively corresponding to the first predetermined transcription size. The audio stream can also be transcribed using at least a second transcribing instance having a second predetermined transcription size that is smaller than the length of the audio stream. The second transcribing instance can provide a plurality of consecutive second transcribed text data snippets each corresponding to the second predetermined transcription size.

Abstract: The present invention relates to the use of an inseparable combination of morphine and at least one opiate antagonist with a bioavailability of less than 5% on oral administration for producing a medicament to be administered orally for treatment of opiate dependency in humans and to the use of an inseparable combination of an opiate and at least one opiate antagonists with a bioavailability of less than 5% on oral administration for producing a medicament to be administered orally for prevention of non-oral opiate abuse in opiate addicts.

Abstract: The present invention relates to the use of an inseparable combination of morphine and at least one opiate antagonist with a bioavailability of less than 5% on oral administration for producing a medicament to be administered orally for treatment of opiate dependency in humans and to the use of an inseparable combination of an opiate and at least one opiate antagonists with a bioavailability of less than 5% on oral administration for producing a medicament to be administered orally for prevention of non-oral opiate abuse in opiate addicts.

Abstract: A method for controlling a pressure (32, 34) in an injection system (14) for an engine (12) of a vehicle (10) comprises the following steps: determining whether the vehicle (10) is decelerating; reducing the delivery rate of a high-pressure pump (16) that supplies fuel to the injection system (14); reducing the pressure in the injection system (14) to a standstill pressure (ps) by means of idle operation of the engine (12); estimating a standstill time (t1) at which the vehicle (10) comes to a standstill; and reducing the delivery rate of the high-pressure pump (16) before the standstill time (t1) is reached, such that the standstill pressure (ps) is attained in the injection system (14) at the standstill time (t1).

Abstract: A method for controlling a pressure (32, 34) in an injection system (14) for an engine (12) of a vehicle (10) comprises the following steps: determining whether the vehicle (10) is decelerating; reducing the delivery rate of a high-pressure pump (16) that supplies fuel to the injection system (14); reducing the pressure in the injection system (14) to a standstill pressure (pS) by means of idle operation of the engine (12); estimating a standstill time (t1) at which the vehicle (10) comes to a standstill; and reducing the delivery rate of the high-pressure pump (16) before the standstill time (t1) is reached, such that the standstill pressure (pS) is attained in the injection system (14) at the standstill time (t1).

Abstract: Use of microcrystalline cellulose and, optionally, a surfactant in an aqueous pharmaceutical composition in order to inhibit the extraction of ephedrine for the purpose of drug abuse.